Evidence map›Paper›PMID 32587843›Full record

ArticleFrontiers in public health2020

Natarajan Murugan, Ramalingam Srinivasan, Athiappan Murugan, Myunghee Kim, Devarajan Natarajan

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Integrated computational investigation ofFrontiers in molecular biosciences · 2026
    Article
  3. Review
  4. The Inhibitory Effect of KerraMedicina (Kaunas, Lithuania) · 2023
    Article
  5. Article
  6. Life (Basel, Switzerland) · 2023
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Natarajan MuruganNatural Drug Research Laboratory, Department of Biotechnology, School of Biosciences, Periyar University, Salem, India.
Ramalingam SrinivasanNatural Drug Research Laboratory, Department of Biotechnology, School of Biosciences, Periyar University, Salem, India.
Athiappan MuruganDepartment of Microbiology, School of Biosciences, Periyar University, Salem, India.
Myunghee KimDepartment of Food Science and Technology, Yeungnam University, Gyeongsan-si, South Korea.
Devarajan NatarajanNatural Drug Research Laboratory, Department of Biotechnology, School of Biosciences, Periyar University, Salem, India.
Periyar University · INYeungnam University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several multidrug-resistant organisms have emerged, which increases the threat to public health around the world and a limited number of therapeutics were available to counteract these issues. Thus, researchers are trying to find out novel antimicrobials to overcome multidrug-resistant issues. The present study aimed to isolate antibacterial principles against the clinical isolates of multidrug-resistant (MDR)

Indexed as

Methicillin-Resistant Staphylococcus aureusRutaceaePlant ExtractsQuinazolinonesQuinolinesSpectroscopy, Fourier Transform InfraredStaphylococcus aureusglycosinePlant ExtractsQuinazolinonesQuinolinesskimmianineantibacterial compoundsarborinechromatographyGycosmis pentaphyllaMDR Staphylococcus aureusskinmmianinespectral study

Identifiers

PMID32587843
PMCPMC7297912
OpenAlexW3035193150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.